TY  - GEN
AU  - Wagner,A D
AU  - Buechner-Steudel,P
AU  - Wein,A
AU  - Schmalenberg,H
AU  - Lindig,U
AU  - Moehler,M
AU  - Behrens,R
AU  - Kleber,G
AU  - Kuss,O
AU  - Fleig,W E
TI  - Gemcitabine, oxaliplatin and weekly high-dose 5-FU as 24-h infusion in chemonaive patients with advanced or metastatic pancreatic adenocarcinoma: a multicenter phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
SN  - 0923-7534
PY  - 2007///0405
KW  - Adenocarcinoma
KW  - drug therapy
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Deoxycytidine
KW  - administration & dosage
KW  - Disease Progression
KW  - Disease-Free Survival
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Infusions, Intravenous
KW  - Male
KW  - Middle Aged
KW  - Organoplatinum Compounds
KW  - Oxaliplatin
KW  - Pancreatic Neoplasms
KW  - Quality of Life
KW  - Survival Rate
KW  - Time Factors
KW  - Treatment Outcome
KW  - Gemcitabine
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/annonc/mdl340
ER  -